Cellectar Biosciences to Host Conference Call on August 12th to Discuss Second Quarter Financial Results and Provide Update on Development Plans Aug 7, 2015
Cellectar Biosciences Announces CLR1502 Development Program to be Classified as Combination Product by U.S. Food and Drug Administration Jun 11, 2015
Cellectar Biosciences Reports First Quarter 2015 Financial Results and Provides Update on Clinical Programs May 21, 2015
Cellectar Biosciences to Host Conference Call on May 21st to Discuss First Quarter 2015 Results and Provide Update on Development Programs May 20, 2015
Cellectar Biosciences Reschedules Release of First Quarter Financials and Quarterly Conference Call May 11, 2015
Cellectar Biosciences to Host Conference Call on May 12th to Discuss First Quarter 2015 Results and Provide Update on Development Programs May 5, 2015
Cellectar Biosciences Initiates Proof-of-Concept Trial of I-131-CLR1404 in Multiple Myeloma Apr 15, 2015
